Emerging data suggests we may have been overzealous with systemic corticosteroid prescribing and that allowing patients to self-manage their exacerbations with steroid rescue therapy may be harmful. However, we can now identify a subgroup of COPD patients who might benefit from systemic corticosteroids to treat their exacerbation.

Guest Authors:  Hope Shrader Sherman, PharmD and Maricar Conson, PharmD, BCACP

Music by Good Talk